Nalidixic acid

Chemical formula: C₁₂H₁₂N₂O₃  Molecular mass: 232.235 g/mol  PubChem compound: 4421

Therapeutic indications

Nalidixic acid is indicated for:

Indication

Population group: only children (1 year - 12 years old)

at least one of
Enterobacter
Escherichia coli
Morganella morganii
Proteus mirabilis
Proteus vulgaris
Providencia rettgeri
Pseudomonas
and additionally Urinary tract infectious disease

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Indication

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

at least one of
Enterobacter
Escherichia coli
Morganella morganii
Proteus mirabilis
Proteus vulgaris
Providencia rettgeri
Pseudomonas
and additionally Urinary tract infectious disease

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Nalidixic acid is contraindicated in the following cases:

Contraindication

at least one of
Alkylating agents
Disorders of porphyrin and bilirubin metabolism

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Structured Product Labeling (SPL) 2007: NEGGRAM Oral suspension
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈